Your browser is no longer supported. Please, upgrade your browser.
Settings
AXGN AxoGen, Inc. daily Stock Chart
AXGN [NASD]
AxoGen, Inc.
Index- P/E- EPS (ttm)-0.41 Insider Own1.80% Shs Outstand32.60M Perf Week-0.93%
Market Cap347.19M Forward P/E- EPS next Y-0.22 Insider Trans5.89% Shs Float31.66M Perf Month6.50%
Income-12.40M PEG- EPS next Q-0.09 Inst Own66.80% Short Float3.68% Perf Quarter23.12%
Sales37.50M P/S9.26 EPS this Y48.70% Inst Trans21.88% Short Ratio7.37 Perf Half Y20.75%
Book/sh0.04 P/B266.25 EPS next Y42.10% ROA-37.40% Target Price12.00 Perf Year102.47%
Cash/sh0.49 P/C21.70 EPS next 5Y- ROE-292.80% 52W Range4.87 - 11.25 Perf YTD18.33%
Dividend- P/FCF- EPS past 5Y42.80% ROI-28.20% 52W High-5.32% Beta0.24
Dividend %- Quick Ratio5.20 Sales past 5Y55.50% Gross Margin83.90% 52W Low118.69% ATR0.38
Employees113 Current Ratio6.20 Sales Q/Q36.60% Oper. Margin-21.50% RSI (14)58.47 Volatility3.61% 3.49%
OptionableYes Debt/Eq22.73 EPS Q/Q31.10% Profit Margin-33.00% Rel Volume0.46 Prev Close10.55
ShortableYes LT Debt/Eq22.73 EarningsFeb 22 AMC Payout- Avg Volume158.12K Price10.65
Recom1.70 SMA200.73% SMA508.63% SMA20029.42% Volume73,503 Change0.95%
Nov-22-16Upgrade Lake Street Hold → Buy $9 → $11
Nov-07-16Reiterated Wedbush Outperform $10 → $12
Nov-03-16Downgrade Lake Street Buy → Hold $9
Aug-04-16Reiterated Wedbush Outperform $9 → $10
May-14-14Initiated Dawson James Buy $5
Oct-31-13Reiterated Ladenburg Thalmann Buy $4.50 → $5.75
Feb-22-17 04:44PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:16PM  AxoGen reports 4Q loss
04:01PM  AxoGen, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results GlobeNewswire
Feb-08-17 07:00AM  AxoGen, Inc. to Report Fourth Quarter and 2016 Full Year Financial Results and Host Conference Call on Wednesday, February 22, 2017 GlobeNewswire
Jan-26-17 04:58PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Jan-18-17 09:30AM  Zacks.com featured highlights: AxoGen, MAG Silver, Triumph Bancorp, UCP and Yelp
Jan-09-17 07:31AM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +10.75%
07:00AM  AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue GlobeNewswire
Jan-05-17 04:01PM  AxoGen Appoints Ivica Ducic Medical Director GlobeNewswire
Jan-03-17 05:06PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers
07:00AM  AxoGen to Participate at AAHS ASPN ASRM Joint 2017 Annual Meeting GlobeNewswire
Dec-30-16 10:53AM  ETFs with exposure to AxoGen, Inc. : December 30, 2016
Dec-14-16 12:44PM  ETFs with exposure to AxoGen, Inc. : December 14, 2016
07:00AM  AxoGen, Inc. announces Avance® Nerve Graft Recipient to be honored on the Donate Life Tournament of Roses Parade Float GlobeNewswire
Dec-10-16 11:03AM  Hedge Funds Are Betting On AxoGen, Inc. (AXGN) at Insider Monkey
Nov-22-16 08:52AM  AxoGen upgraded by Lake Street
Nov-21-16 07:00AM  AxoGen, Inc. Announces Commercial Release and First Clinical Implant of Avive Soft Tissue Membrane GlobeNewswire
Nov-17-16 07:00AM  AxoGen, Inc. to Present at the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-15-16 07:00AM  AxoGen, Inc. to Host Analyst and Investor Event on November 21, 2016 GlobeNewswire
Nov-09-16 01:04PM  AXOGEN, INC. Financials
Nov-07-16 12:07PM  ETFs with exposure to AxoGen, Inc. : November 7, 2016
Nov-04-16 11:31AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016 -6.40%
Nov-02-16 06:19PM  AxoGen reports 3Q loss
04:17PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:08PM  AXOGEN, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  AxoGen, Inc. Reports Financial Results for Third Quarter 2016 GlobeNewswire
07:07AM  Q3 2016 AxoGen Inc Earnings Release - After Market Close
Oct-31-16 04:17PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agr
Oct-26-16 07:00AM  AxoGen, Inc. Announces the Refinancing of its Debt Facility GlobeNewswire
Oct-19-16 07:00AM  AxoGen, Inc. to Report Third Quarter Financial Results and Host Conference Call on Wednesday, November 2, 2016 GlobeNewswire
Oct-13-16 04:33PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
04:05PM  AxoGen Announces Closing of Public Offering of Common Stock and Underwriters Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Oct-12-16 09:39AM  ETFs with exposure to AxoGen, Inc. : October 12, 2016
Oct-07-16 09:00AM  AxoGen Announces Pricing of Public Offering of Common Stock GlobeNewswire +11.04%
Oct-06-16 04:05PM  AxoGen Announces Proposed Public Offering of Common Stock GlobeNewswire
Sep-27-16 09:52AM  ETFs with exposure to AxoGen, Inc. : September 27, 2016
Sep-26-16 08:41AM  Allergan Gets FDA Approval for New Line of Breast Implants
Sep-19-16 09:02AM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:00AM  AxoGen, Inc. Appoints Amy Wendell to Board of Directors GlobeNewswire
Sep-15-16 07:00AM  AxoGen to Participate at 71st Annual American Society for Surgery of the Hand Meeting GlobeNewswire
Sep-12-16 10:13AM  2 Biotech Stocks that Turned $8,000 into over $250,000 at Motley Fool
07:00AM  AxoGen, Inc. to Participate at the American Association of Oral and Maxillofacial Surgeons 98th Annual Meeting GlobeNewswire
Sep-07-16 10:20AM  Allergan Takes Over RetroSense; Boosts Eye Care Pipeline
Aug-29-16 05:13PM  Your Complete Guide to the Generic Drug Industry
11:02AM  ETFs with exposure to AxoGen, Inc. : August 29, 2016
Aug-12-16 12:50PM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 07:00AM  AxoGen, Inc. to Present at Wedbush PacGrow Healthcare Conference 2016 GlobeNewswire +8.35%
Aug-03-16 07:31PM  AxoGen reports 2Q loss +7.32%
04:12PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:10PM  AxoGen, Inc. Reports Financial Results for Second Quarter 2016 GlobeNewswire
07:07AM  Q2 2016 AxoGen Inc Earnings Release - After Market Close
Jul-29-16 01:15PM  ETFs with exposure to AxoGen, Inc. : July 29, 2016
Jul-20-16 07:00AM  AxoGen, Inc. to Report Second Quarter Financial Results and Host Conference Call on Wednesday, August 3, 2016 GlobeNewswire
Jul-11-16 04:32PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Jul-06-16 04:31PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Jun-27-16 07:00AM  AxoGen, Inc. Added to Russell 2000® Index GlobeNewswire
Jun-21-16 12:47PM  ETFs with exposure to AxoGen, Inc. : June 21, 2016
07:00AM  AxoGen, Inc.s Avance® Nerve Graft Data to be Presented at 2016 Federation of European Societies for Surgery of the Hand International Congress GlobeNewswire
Jun-16-16 07:00AM  AxoGen to Present at JMP Securities Healthcare Conference 2016 GlobeNewswire
May-31-16 04:41PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Securi
May-26-16 07:14PM  ETFs with exposure to AxoGen, Inc. : May 26, 2016
May-13-16 10:21AM  AxoGen, Inc. :AXGN-US: Earnings Analysis: Q1, 2016 By the Numbers
May-04-16 07:12PM  AxoGen reports 1Q loss
04:21PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:10PM  AxoGen, Inc. First Quarter Revenue Increases 64% Over Prior Year to $8.1 Million GlobeNewswire
04:09PM  AXOGEN, INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q1 2016 AxoGen Inc Earnings Release - After Market Close
Apr-29-16 09:52AM  AxoGen (AXGN) Enters Overbought Territory
Apr-20-16 07:24AM  AxoGen, Inc. to Report First Quarter Results GlobeNewswire
Apr-08-16 06:58AM  AxoGen, Inc. to Feature Nerve Repair Solutions at the American College of Oral and Maxillofacial Surgeons (ACOMS) Annual Scientific Conference and Exhibition GlobeNewswire
Mar-30-16 07:05AM  AxoGen, Inc. Launches AcroVal(TM) Neurosensory & Motor Testing System GlobeNewswire
Mar-18-16 03:55PM  AXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Mar-14-16 05:10PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:21AM  Kevin Leach Appointed Vice President of Marketing of AxoGen, Inc. GlobeNewswire
Mar-09-16 07:09AM  AxoGen, Inc. to Participate at the 28th Annual ROTH Growth Conference GlobeNewswire
Mar-01-16 04:30PM  CFO Moves: Delphi Automotive, Hain Celestial Group, AxoGen Inc. at The Wall Street Journal
07:04AM  AxoGen Appoints Peter J. Mariani Chief Financial Officer GlobeNewswire
Feb-29-16 08:17PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Offi
06:44PM  AXOGEN, INC. Files SEC form 10-K, Annual Report
06:31PM  AxoGen reports 4Q loss
04:18PM  AxoGen Inc. Reports Record Revenue Results GlobeNewswire
07:07AM  Q4 2015 AxoGen Inc Earnings Release - After Market Close
Feb-10-16 07:02AM  AxoGen, Inc. to Report Fourth Quarter and Full Year Results on February 29, 2016 GlobeNewswire
Jan-08-16 09:15AM  Edited Transcript of AXGN earnings conference call or presentation 5-Nov-15 9:30pm GMT
Dec-31-15 04:14PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Dec-28-15 04:48PM  AxoGen, Inc. Avance(R) Nerve Graft Recipient to be Honored on Donate Life Rose Parade Float GlobeNewswire
Dec-24-15 10:47AM  AxoGen, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-15-15 04:50PM  AXOGEN, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Dec-10-15 03:49PM  Do Hedge Funds Love AxoGen, Inc. (AXGN)? at Insider Monkey
Nov-23-15 07:50AM  Equity Market Movement at a Glance - Research on AxoGen, Ampio Pharmaceuticals, Ultra Clean Holdings and Willbros Group Accesswire
Nov-05-15 04:17PM  AxoGen Inc. Third Quarter Revenue Exceeds $8 Million GlobeNewswire
04:16PM  AXOGEN, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q3 2015 AxoGen Inc Earnings Release - After Market Close
Oct-16-15 07:03AM  AxoGen, Inc. to Report Third Quarter Results on November 5, 2015 GlobeNewswire
Oct-08-15 07:06AM  AxoGen, Inc. to Present at the Dawson James Securities Small Cap Growth Conference GlobeNewswire
Oct-01-15 11:12AM  AxoGen, Inc. Earnings Q2, 2015
Sep-29-15 07:05AM  AxoGen, Inc. to Attend American Association of Oral and Maxillofacial Surgeons (AAOMS) 97th Annual Meeting GlobeNewswire
Sep-16-15 09:04AM  AxoGen (AXGN) Looks Good: Stock Adds 13.8% in Session
Sep-15-15 08:38AM  3 Reasons Why AxoGen (AXGN) is a Great Momentum Stock +13.82%
Sep-14-15 07:22AM  Will AxoGen (AXGN) Continue to Surge Higher?
AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf human nerve allograft for bridging nerve discontinuities without the comorbidities associated with another surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. It also offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device, as well as provides AxoTouch two point discriminator, a tool used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals through a direct sales force and independent distributors. It markets its products in the United States, the United Kingdom, Israel, Canada, Greece, Chile, Switzerland, Austria, and Spain. AxoGen, Inc. is headquartered in Alachua, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Engels John PVPOct 07Buy7.504,00030,00098,425Oct 14 01:37 PM
Zaderej Karen L.CEOOct 07Buy7.5010,00075,000242,147Oct 14 01:37 PM
MARIANI PETER JChief Financial OfficerOct 07Buy7.503,33324,9983,333Oct 14 03:13 PM
Leach KevinVice President MarketingOct 07Buy7.502,00015,0002,000Oct 14 03:14 PM
Wendell Amy McBrideDirectorOct 07Buy7.5013,33399,99813,333Oct 14 03:36 PM
Gold Mark StephenDirectorAug 17Option Exercise3.603,75013,500325,248Aug 19 03:25 PM
Mandato Joseph MDirectorAug 09Sale8.3042,168349,9941,226,773Aug 10 07:28 PM
Mandato Joseph MDirectorAug 08Sale8.63107,450927,2941,268,941Aug 10 07:28 PM
Flynn James EPossible Member of 10% GroupJul 21Sale6.70102,136684,3113,000,000Jul 21 04:26 PM
Flynn James EPossible Member of 10% GroupJul 18Sale6.8741,425284,5903,102,136Jul 18 06:20 PM
Flynn James EPossible Member of 10% GroupJul 15Sale7.3231,788232,6883,143,561Jul 18 06:20 PM
Flynn James EPossible Member of 10% GroupJul 14Sale7.70206,0901,586,8933,175,349Jul 18 06:20 PM
Hansen David KChief Accounting OfficerMay 31Option Exercise0.279,8212,6529,821Jun 01 05:00 PM